Fig. 2From: A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLCConsensus cluster analyses based on CRGs and CRDEGs. (A) Three clusters were divided by consensus cluster analysis coupled with cumulative distribution function plot and delta area plot; (B) Heatmap of CRGs expression allied with clinical characteristic of three clusters; (C) Venn diagram of CRDEGs; (D) Based on CRDEGs, three clusters were divided by consensus cluster analysis coupled with cumulative distribution function and delta area plots; (E) Heatmap of CRDEGs expression combined with other clinical features in three subtype clusters; (F) Variances in CRGs expression level among three gene clusters; (G) Immune infiltration through ssGSEA among the three clusters; (H) OS among three clusters. (I) Principal component analysis (PCA) of the three clusters. (*P < 0.05; ** P < 0.01; and *** P < 0.001; Ns, not significant) OS, overall survival; PCA, principal component analysis; ssGSEA, single sample gene set enrichment analysis. CRGs, cuproptosis-related genes. CRDEGs, cuproptosis-related differentially expressed genes; OS, overall survivalBack to article page